MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1K
30-iyn, 22:00:00 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Business Wire
·
13 daqiqa oldin
Powerus (Nasdaq: PUSA) Unveils Fully Autonomous Drone Interceptors at AUSA 2026
PR Newswire
·
13 daqiqa oldin
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
The National Law Review
·
11 daqiqa oldin
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales a
WSJ
·
45 daqiqa oldin
Nasdaq Futures Fall as Global AI Selloff Intensifies
Profil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia